News and events

RT @kchalkidou: "German biotech company CureVac, which is developing a potential COVID-19 vaccine, has secured a 75 million euro ($85 milli…

RT @PaulJBelcher: #EU scrambles to buy intensive care #drugs to tackle #COVID shortages “shortages of analgesics, antibiotics, muscle rela…

RT @CGDev: In our race to beat COVID-19, speed and agility matter, but so does the resource development process — which technology, for who…

Japan supercomputer suggests changes to travel, work amid airborne virus threat : The Asahi Shimbun https://t.co/22s8ru4pxs

RT @dollendorf: Now in print: looking forward to using this work as a springboard to further work with our #African colleagues! https://t.c…

RT @CGDev: #COVID19 has cost 130,000+ American lives & projects $8 trillion in economic losses; and the threat is not over. "Actions to wi…

RT @kchalkidou: "Pragmatic trials and early HTAs need to be conducted in different resource contexts to test effectiveness and cost effecti…

RT @Yadav_supplychn: #COVID19 has brought considerable attention to medical #supplychains. In new #CGDDebates Iain Barton @CHAI_health @PKe…

RT @HelenBranswell: The U.S. government has formally notified the UN Secretary General is it pulling out of @WHO. https://t.co/tcYsgeKjjf

Transmission du Covid-19 par l'air: l'OMS reconnaît que des «preuves émergent» https://t.co/QSN2VwdL2S